Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go?
about
Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scoresThe galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure.Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver diseaseAutologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?Association of preoperative parameters with postoperative mortality and long-term survival after liver transplantationSarcopenia in the prognosis of cirrhosis: Going beyond the MELD score.Time-dependent predictive accuracy in the presence of competing risksInterleukin-10 genotype correlated to deficiency syndrome in hepatitis B cirrhosis.Liver transplantation for viral hepatitis.Prognostic value of (13)C-phenylalanine breath test on predicting survival in patients with chronic liver failure.Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trailSex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study.Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism.Medical Care of the Patient With Compensated Cirrhosis.Predicting AKI in emergency admissions: an external validation study of the acute kidney injury prediction score (APS).Important predictor of mortality in patients with end-stage liver disease.Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials.Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients.Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma.Circulating vascular endothelial growth factor and nitric oxide in patients with liver cirrhosis: A possible association with liver function impairmentNovel management of acute or secondary biliary liver conditions using hepatically differentiated human dental pulp cells.Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma.The evolution in the prioritization for liver transplantation.Value of baseline platelet count for prediction of complications in primary biliary cirrhosis patients treated with ursodeoxycholic acid.Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in Greek patients.Nutritional assessments for ordinary medical care in patients with chronic liver disease.Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein.Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients.N-butyl-2 cyanoacrylate (NBCA) embolus in the graft portal vein after portosystemic collateral embolization in liver transplantation recipient: what is the clinical significance?Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias.Relationship between severity of liver dysfunction and the relative ratio of liver to aortic enhancement (RE) on MRI using hepatocyte-specific contrast.
P2860
Q33280499-55E581C3-106B-47DB-B67C-D49684DD1A58Q33476505-807BDDB8-E5D1-4A32-9860-B6F794BC2DCBQ33506549-359EF79B-D584-4C33-80B8-757BB55DF9B1Q33608736-3810F0BB-4FBF-4A17-AE57-B7175F12ABAFQ33648955-1D688B54-CC72-420F-B164-9C809F4D3FCDQ33900601-66F4FC79-60E3-4025-9718-5610DB44753AQ34306742-A9ABD980-9386-4392-A266-0450D4F11B2BQ34469838-BDC3EA52-365F-4725-847F-652C3ABF2F10Q35049967-35D22D81-286F-410A-8CEE-08797246A118Q35819511-C4281193-BF53-4CB0-9A69-EC2A3DFF2002Q35881672-E732B818-08B1-4E51-BCBB-28317A194D4EQ36011868-48C0E451-0868-4F15-AB82-4DF72636F172Q36027124-986ACB40-3161-42A7-9FCD-17A917D0B4FBQ36179924-EF3A5BDE-BDD0-496C-A11E-B85AC55561C5Q36711606-429C102C-D2D5-4DD4-B9DA-65D5EA0897BAQ37133717-B2D637D8-A032-4748-BC1F-9C75D522DDEBQ37157053-6E514A5E-AAF5-43D8-BF3B-B23696D4FEB3Q37298904-353DF8D7-90B3-4923-83DB-7BDADF11973FQ37678908-76584E06-FDBE-4A37-B075-4EAE895D4F9AQ37704140-83ADB19B-F0BB-4AF1-99E1-DE3D56EAD9BBQ38120248-E43FB6BA-B97B-4E99-A55A-90A98DD1B056Q38414766-ABD54742-1192-4D65-9557-1F6A3472C7F0Q39518023-FCFCB8CD-1048-4AE1-BEBB-19756413CBA6Q40086254-7BDCE45D-E1E1-40C7-8CC0-E3829AC1943DQ41872249-40004186-9E82-4673-9320-0B1CB293A51BQ42107098-EB2D94CB-C30C-4BEC-9275-1C0314CD0663Q42252781-7D8C5F01-3B0E-49A0-9F17-9CE9A7E2F878Q42406771-5BB9E1F9-F55B-4F5A-9171-DD9977061374Q43576890-4D3B08C7-94A8-4A43-AD0E-61EC7811829AQ43606466-A5F57B96-8F18-4739-B783-02D2662C0739Q46632251-100D8205-B263-4AE6-A7F6-A4C81FEBB866Q47431015-381CCAEE-7727-4ABB-A78F-6B6CB20DE757Q50531302-046A83ED-6CB1-4453-95F7-507645249126Q50969803-934FBC99-D6BF-45DC-B323-AAF26B4C207DQ51770726-CAB0C8CE-6696-455B-9BEE-6CF5C410A869Q53112856-85236102-930F-4E73-9C45-254365936247
P2860
Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prognostic models including th ...... are we and where should we go?
@ast
Prognostic models including th ...... are we and where should we go?
@en
type
label
Prognostic models including th ...... are we and where should we go?
@ast
Prognostic models including th ...... are we and where should we go?
@en
prefLabel
Prognostic models including th ...... are we and where should we go?
@ast
Prognostic models including th ...... are we and where should we go?
@en
P1476
Prognostic models including th ...... are we and where should we go?
@en
P2093
Erik Christensen
P304
P356
10.1016/J.JHEP.2004.06.005
P577
2004-08-01T00:00:00Z